InvestorsHub Logo
Followers 13
Posts 2213
Boards Moderated 0
Alias Born 08/11/2017

Re: None

Monday, 06/15/2020 2:15:18 PM

Monday, June 15, 2020 2:15:18 PM

Post# of 1715
Cardiff Oncology Data Continues to Demonstrate Efficacy, Durability and Safety of Onvansertib in Patients with Difficult-to-Treat Relapsed/Refractory AML

https://cardiffoncology.investorroom.com/2020-06-15-Cardiff-Oncology-Data-Continues-to-Demonstrate-Efficacy-Durability-and-Safety-of-Onvansertib-in-Patients-with-Difficult-to-Treat-Relapsed-Refractory-AML

MegaDeath, changed due to circumstances of COVID-19 pandemic.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDF News